EP3055325
NOVEL DERIVATIVE OF AN INSULIN ANALOGUE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.10.2014EP published:
3.1.2018EP application number:
14780512.1
EPO information:
European Patent Register
Max expiry date:
2.10.2034
Title:
NOVEL DERIVATIVE OF AN INSULIN ANALOGUE
Timeline
Today
3.10.2014EP application
3.1.2018EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
MADSEN, PeterAddress:
Bagsværd, DK
Name:
TAGMOSE, Tina MøllerAddress:
Bagsværd, DK
Name:
NAVER, HelleAddress:
Bagsværd, DK
Name:
KJELDSEN, Thomas BørglumAddress:
Bagsværd, DK
Priority
Number:
13187626Date:
7.10.2013Country:
EP
Classification
Categories:
C07K 14/62, A61K 38/28